
Quantum BioPharma Taps Thermo Fisher for Phase 2 Lucid-MS Trial
Quantum BioPharma partners with Thermo Fisher's clinical research business to launch a Phase 2 trial of Lucid-MS, a novel neuroprotective MS treatment.
42 minutes ago
NewsRamp

Quantum BioPharma partners with Thermo Fisher's clinical research business to launch a Phase 2 trial of Lucid-MS, a novel neuroprotective MS treatment.
42 minutes ago

about 1 hour ago

about 1 hour ago

about 2 hours ago

about 3 hours ago

about 3 hours ago
about 3 hours ago

about 3 hours ago

about 4 hours ago

about 4 hours ago

about 5 hours ago

about 5 hours ago

1 day ago
3 days ago
5 days ago
6 days ago
7 days ago
42 minutes ago
about 1 hour ago
about 2 hours ago
about 3 hours ago
about 3 hours ago
1 day ago
5 days ago
5 days ago
6 days ago
6 days ago
42 minutes ago
about 1 hour ago
about 5 hours ago
about 7 hours ago
about 7 hours ago
about 1 hour ago
about 2 hours ago
about 3 hours ago
about 3 hours ago
about 5 hours ago
about 3 hours ago
about 6 hours ago
about 6 hours ago
about 7 hours ago
about 7 hours ago
For newswires & publishers
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.